查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138403

全球血管內動脈瘤修復市場-2022-2029

Global Endovascular Aneurysm Repair Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

腹主動脈瘤血管內治療的創新技術有望推動市場增長。

已經提出了一種基於聚合物的技術來通過血管內方法治療 AAA。正在為臨床目的開發兩種不同的基於聚合物的平台。用於周向密封動脈瘤的聚合物裝置已被證明是安全有效的。此外，通過將 O 形環與主動脈壁相適配，這種基於聚合物的平台提供了對動脈瘤的定制密封，並且可以在不影響頸部擴張的情況下保持穩定多年。我可以做到。使用聚合物通道而不是織物支撐的傳統金屬支架框架使此類平台變薄，有可能擴大患者對微創 EVAR 治療的適用性。這種技術的影響已經很大。因此，利用聚合物的特性定制和封閉動脈瘤的可能性代表了 EVAR 手術的一次重大革命。因此，上述聲明預計將在預測期內推動市場。

約束

與開放式手術相比，EVAR 手術的支架瞬時動脈瘤和充血性心力衰竭的風險、不良的報銷政策以及擴張成本。這些是預計在預測期內阻礙市場的一些因素。

COVID-19 影響分析

COVID-19 大流行對醫療保健系統和市場產生了適度影響。大流行包括執行的心血管手術數量顯著下降，包括腹主動脈瘤 (AAA) 修復。例如，對 COVID-19 傳播的擔憂導致英國大部分地區在封鎖期間暫停 AAA 篩查（包括監測），並且（由於 NHS 內的能力下降）存在手術干預延遲的風險。正在考慮緩解。此外，破裂的AAA死亡率高，需要進行AAA篩查。每年約有 300,000 名男性接受篩查，其中約 1% 被發現患有 AAA，但仍有約 15,000 名男性未經檢測。因此，預計市場在預測期內將活躍。

行業分析

血管內動脈瘤修復市場根據各種行業因素（包括未滿足的需求、定價分析、供應鏈分析和監管分析）對市場進行深入分析。

全球血管內動脈瘤修復市場報告提供大約 45 多個市場數據表、40 多個圖表和 180 頁內容。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品類型劃分的市場細分
  • 按指標劃分的市場細分
  • 按年齡組劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 腹主動脈瘤血管內治療的創新技術有望推動市場增長。
    • 約束因素
      • 與開放手術相比，EVAR 手術的成本上漲預計將阻礙市場增長。
    • 市場進入機會
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 開窗型 EVAR
  • 輔助覆膜支架
  • 分支覆膜支架
  • 其他

第 8 章適應症

  • 腹主動脈瘤 (AAA)
  • 胸主動脈瘤 (TAA)
  • 胸腹主動脈瘤 (TAAA)
  • 其他

第 9 章按年齡分類

  • 兒科
  • 成人
  • 老年

第 10 章，最終用戶

  • 醫院
  • 門診手術中心
  • 診所
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 13 章公司簡介

  • Cardinal Health
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Lombard Medical Limited
  • Endologix Inc.
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • JOTEC GmbH
  • W. L. Gore & Associates, Inc.
  • Cook Group Incorporated
  • Medtronic plc（*未詳盡列出*）

第 14 章數據M

簡介目錄
Product Code: DMMD4604

Market Overview

Endovascular Aneurysm Repair market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.6% during the forecast period (2022-2029).

An aortic aneurysm is a condition in which the aorta becomes enlarged. Abdominal pain, low blood pressure, loss of consciousness, and even death can result from these diseases. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical procedure that can treat abdominal and thoracic aortic aneurysms. It is a less invasive and less time-consuming alternative to open surgery for abdominal aortic aneurysms (AAA).

Market Dynamics

Innovative technologies in the endovascular treatment of abdominal aortic aneurysms are expected to drive market growth.

Polymer-based technology has been proposed for treating AAA with an endovascular approach. Two different polymer-based platforms have been developed for clinical purposes. The polymer device to create a circumferential sealing of the aneurysm has proven safe and effective. Moreover, adapting the O-ring to the aortic wall, this polymer-based platform offers a customized sealing of the aneurysm, which remains stable over the years without influencing neck dilatation. The low profile of such a platform based on polymer channels rather than traditional metallic stent frames to support the fabric may expand patient applicability for a minimally invasive EVAR treatment. The impact of this kind of technology is already significant. Therefore, the possibility of using polymer characteristics to create a customized sealing of the aneurysm has been a great revolution in EVAR procedures. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

The stent moment leads to the risk of an aneurysm and congestive heart failure, insufficient reimbursement policies, and the inflated cost of EVAR procedures compared to open surgeries. These are some of the factors that the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The pandemic included a substantial reduction in the number of cardiovascular procedures performed, including repair of Abdominal Aortic Aneurysms (AAA). For instance, AAA screening (including surveillance) in most areas of the UK was paused during the lockdown due to concerns about COVID-19 transmission and while strategies are considered regarding mitigating risk from delayed surgical intervention (as a result of reduced capacity within the NHS). Moreover, ruptured AAA carries a high mortality and screening for AAA. Circa 300,000 men are offered screening annually, of whom around 1% are found to have an AAA, while approximately 15,000 men are yet to tests. Thus, the market will undergo impetus during the forecast period.

Industry Analysis

The endovascular aneurysm repair market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

The adjunctive stent graft segment is expected to hold the largest market share in the endovascular aneurysm repair market.

The adjunctive stent-graft segment accounted for the largest market share in 2021. Adjunctive stenting significantly reduces the risk of postoperative stent-graft limb occlusion without obvious compromise to the aneurysm repair. Endovascular grafting is a minimally invasive method to treat an aortic aneurysm. Through minor incisions in the groin, a stent graft (a fabric tube supported by metal wire stents that support the weak area in the aorta) is placed into the aneurysm. Endovascular aneurysm treatment does not require a major incision and has a significantly quicker recovery than traditional open surgery. Therefore, it increased the demand for adjunctive stent graft, due to which the market is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global endovascular aneurysm repair market.

North America accounted for the highest revenue share in 2021. The increasing prevalence of aneurysms and the rising geriatric population are more prone to this condition, due to which the market is expected to boost in the forecast period. For instance, Aortic aneurysms have an incidence of 5-10 cases per 100,000 in the United States and are more common in men over 60. Though aortic aneurysms do not directly cause death, complications arising from an aneurysm - such as dissection or rupture - cause approximately 15,000 deaths annually. AA primarily affects elderly males in the sixth and seventh decades of life with tobacco use, hypertension and atherosclerosis risk factors. For AAA, individuals with first-degree family members with the disease are at two-fold risk of developing AAA compared to patients with no family history. Moreover, according to the Population Reference Bureau report, the number of Americans aged 65 and up is expected to double by 2060, from 46 million to nearly 98 million. Therefore, it increases the demand for AAA treatments such as EVAR, due to which the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the endovascular aneurysm repair market are Cardinal Health, Lombard Medical Limited, Endologix Inc., Terumo Corporation, MicroPort Scientific Corporation, JOTEC GmbH, W. L. Gore & Associates, Inc., Cook Group Incorporated and Medtronic plc.

Medtronic plc:

Overview:

Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

Heli-FX EndoAnchor system: The Heli-FX EndoAnchor system is intended to provide fixation and sealing between endovascular aortic grafts and the native artery.

The global endovascular aneurysm repair market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Indication
  • 3.3. Market Snippet by Age
  • 3.4. Market Snippet by End user
  • 3.5. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovative technologies in the endovascular treatment of abdominal aortic aneurysms are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The inflated cost of EVAR procedures compared to open surgeries is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Reimbursement Analysis
  • 5.4. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Fenestrated EVAR*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Adjunctive Stent Graft
  • 7.4. Branched Stent Graft
  • 7.5. Others

8. By Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 8.1.2. Market Attractiveness Index, By Indication Segment
  • 8.2. Abdominal Aortic Aneurysm (AAA)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Thoracic Aortic Aneurysm (TAA)
  • 8.4. Thoracoabdominal Aortic Aneurysm (TAAA)
  • 8.5. Others

9. By Age

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
    • 9.1.2. Market Attractiveness Index, By Age Segment
  • 9.2. Pediatric*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Adult
  • 9.4. Geriatric

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Hospital*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgery Centers
  • 10.4. Clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Cardinal Health*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Lombard Medical Limited
  • 13.3. Endologix Inc.
  • 13.4. Terumo Corporation
  • 13.5. MicroPort Scientific Corporation
  • 13.6. JOTEC GmbH
  • 13.7. W. L. Gore & Associates, Inc.
  • 13.8. Cook Group Incorporated
  • 13.9. Medtronic plc (*LIST NOT EXHAUSTIVE*)

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us
  • 14.3. Contact Us